Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us

Jan Molenaar

Group leader
Prof. dr. Jan Molenaar leads a research group in the Princess Máxima Center, which focuses on precision medicine in pediatric cancer.
Phone +31 6 18051678
Email j.j.molenaar@prinsesmaximacentrum.nl

Publications

113 publications in total

  • Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression

    • aug. 2025
    • Jelena, Milosevic, et al
    • Cancer letters

  • Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer

    • feb. 2025
    • Seok-Young, Kim, et al
    • Science advances

  • Complex structural variation is prevalent and highly pathogenic in pediatric solid tumors

    • nov. 2024
    • Ianthe A E M, van Belzen, et al
    • Cell genomics

  • Neuroblastoma plasticity during metastatic progression stems from the dynamics of an early sympathetic transcriptomic trajectory

    • nov. 2024
    • Benjamin, Villalard, et al
    • Nature communications

  • Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy

    • feb. 2024
    • Judith, Wienke, et al
    • Cancer Cell
View all publications